[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339580-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339580-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","practical-management-of-renal-cell-carcinoma-integrating-current-approaches-with-advances-in-bone-metastasis-treatment","Practical management of renal cell carcinoma - integrating current approaches with advances in bone metastasis treatment","","Practical management of renal cell carcinoma focuses on how metastasis to bone drives severe, potentially fatal complications such as osteolytic lesions, pathological fractures, hypercalcemia, and spinal cord compression, leading to poorer quality of life and higher morbidity. While nephrectomy remains foundational for localized disease, bone invasion requires coordinated orthopedic and oncologic care. The text reviews the biology of osteolytic mechanisms involving RANK/RANKL/OPG and cytokine signaling, and summarizes current and emerging targeted, immunologic, and surgical strategies, emphasizing the need for improved outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/practical-management-of-renal-cell-carcinoma-integrating-current-approaches-with-advances-in-bone-metastasis-treatment/339580/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/practical-management-of-renal-cell-carcinoma-integrating-current-approaches-with-advances-in-bone-metastasis-treatment/339580.png","ImageObject",300,407,{"name":42,"@type":43},"Maeve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are bone metastases particularly dangerous in renal cell carcinoma?","Question",{"text":63,"@type":64},"Bone metastases are commonly osteolytic and can cause fractures, hypercalcemia, severe pain, and spinal cord compression, which worsen survival and quality of life.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does nephrectomy play in renal cell carcinoma treatment?",{"text":68,"@type":64},"Nephrectomy remains a foundational treatment for localized RCC, but bone invasion often requires additional, coordinated orthopedic and oncologic interventions.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the RANK/RANKL/OPG system contribute to osteolytic bone metastases?",{"text":72,"@type":64},"RCC disrupts the RANK/RANKL/OPG pathway, increasing osteoclastogenesis by shifting signaling toward bone resorption through tumor-driven production of RANKL and related cytokines.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339580,1790216764,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","EFORT Open Reviews (2024) 9 488–502 [https://doi.org/10.1530/EOR-23-0178](https://doi.org/10.1530/EOR-23-0178)  \nONCOLOGY  \n\n| Practical management of renal cell carcinoma: integrating current approaches with advances in bone metastasis treatment\u003Cbr>Irina-Anca Eremia1,2, Bogdan Serban1,3, Mihnea Popa1,3, Adela Iancu1, Silvia Nica1,2 and Catalin Cirstoiu1,3\u003Cbr>1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania\u003Cbr>2Department of Emergency Medicine, Emergency University Hospital, Bucharest, Romania\u003Cbr>3Department of Orthopaedics and Traumatology, Emergency University Hospital Bucharest, Romania\u003Cbr>Correspondence should be addressed to B Serban Email [Bogdan.serban@umfcd. ro](Bogdan.serban@umfcd. ro) |\n| --- |\n| Renal cell carcinoma (RCC) is a common type of tumor that can develop in the kidney. It is responsible for around one-third of all cases of neoplasms. RCC manifests itself in a variety of distinct subtypes. The most frequent of which is clear cell RCC, followed by papillary and chromophobe RCC.\u003Cbr>RCC has the potential for metastasis to a variety of organs; nevertheless, bone metastases are one of the most common and potentially fatal complications. These bone metastases are characterized by osteolytic lesions that can result in pathological fractures, hypercalcemia, and other complications, which can ultimately lead to a deterioration in quality of life and an increase morbidity.\u003Cbr>While nephrectomy remains a foundational treatment for RCC, emerging evidence suggests that targeted therapies, including tyrosine kinase inhibitors and T cell checkpoint inhibitors, may offer effective alternatives, potentially obviating the need for adjuvant nephrectomy in certain cases of metastatic RCC\u003Cbr>Bone metastases continue to be a difficult complication of RCC, which is why more research is required to enhance patient outcome.\u003Cbr>Keywords: bone metastases; fatal complications; renal cell carcinoma |\n\nIntroduction  \nRenal cell carcinoma (RCC) is a prevalent cancer contributing notably to global cancer statistics (1, 2) . Distinct histologic subtypes, notably clear cell RCC (ccRCC), papillary RCC (pRCC), and chromophobe RCC (chrRCC), define this disease (3, 4), each presenting unique genetic and physiological characteristics (5) . Metastatic RCC (mRCC) generally has an unfavorable prognosis (6, 7) .  \nIn its localized form, nephrectomy – either partial or radical – serves as the primary treatment, offering hope for those with kidney-confined disease (8, 9) . However,  \nPublished by Bioscientifica Ltd.  \n[www.efortopenreviews.org](www.efortopenreviews.org)  \n© 2024 the author(s)  \nwhen RCC invades the bone, complications such as fractures, hypercalcemia, severe pain, and spinal cord compression emerge (10), demanding orthopedic surgical intervention. These interventions aim to alleviate symptoms, especially since RCC bone metastases tend to be osteolytic (11) . Even with advancements like T cell checkpoint and tyrosine kinase inhibitors, managing bone metastasis remains challenging (12, 13) .  \nInnovations in surgical techniques have been introduced to improve outcomes and minimize recovery times (14, 15) . Successful RCC management mandates a  \nThis work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.  \nOncology  \nEFORT Open Reviews (2024) 9 488–502 [https://doi.org/10.1530/EOR-23-0178](https://doi.org/10.1530/EOR-23-0178)  \ncollaborative effort from medical oncologists. radiation oncologists, and orthopedic surgeons (16, 17) . Despite some treatments offering limited effects, drugs likesoratenib, sunitinib, and cMET inhibitors are showing potential (19, 19, 20, 21, 22) .  \nThe osteolytic mechanism of RCC bone metastases is intricate, suggesting an interplay between abnormal bone remodeling and tumor growth. Such metastases usually indicate a bleak prognosis, with factors like elevated alkaline phosphatase levels, C-reactive protein, and the presence of extraosseous metastas","cbCaivsT7vJsdgaA","https://ap.wps.com/l/cbCaivsT7vJsdgaA","pdf",2545753,15,"English","# Introduction\n# RCC metastasis pathology\n## RANK/RANKL/OPG pathway disruption\n## Cytokine-driven osteoclast activation","[{\"question\":\"Why are bone metastases particularly dangerous in renal cell carcinoma?\",\"answer\":\"Bone metastases are commonly osteolytic and can cause fractures, hypercalcemia, severe pain, and spinal cord compression, which worsen survival and quality of life.\"},{\"question\":\"What role does nephrectomy play in renal cell carcinoma treatment?\",\"answer\":\"Nephrectomy remains a foundational treatment for localized RCC, but bone invasion often requires additional, coordinated orthopedic and oncologic interventions.\"},{\"question\":\"How does the RANK/RANKL/OPG system contribute to osteolytic bone metastases?\",\"answer\":\"RCC disrupts the RANK/RANKL/OPG pathway, increasing osteoclastogenesis by shifting signaling toward bone resorption through tumor-driven production of RANKL and related cytokines.\"}]","Practical management of renal cell carcinoma - integrating current approaches with advances in bone metastasis treatment | PDF",1790031086,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32a7fa7ea85d57ec62db01904a47033e.webp",983,1269,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53756716b2d63f2de0955ceb6af412de.webp",982,1268,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53d44d415660578d2348eded81d04b3d.webp",981,1266,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80b8ceb56a88549c4293cdcb6d0032e9.webp",980,1265]